Oncolytic virotherapy may be a means of improving the dismal prognosis of malignant brain
tumors. The rat H-1 parvovirus (H-1PV) suppresses tumors in preclinical glioma models, …

Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still
essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive …

Background Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month
progression-free survival of approximately 50% and a median survival of about 11 months. …

The ubiquitin–proteasome pathway has been identified as a potential molecular target for
cancer therapy. In this study, we investigated the effect of the proteasome inhibitor bortezomib …

Introduction The aim of this retrospective analysis was to investigate the efficacy and safety
of nonpegylated liposomal doxorubicin (NPLD) as part of R-CHOP (rituximab, …

We retrospectively analyzed and compared the efficacy and toxicity of azacitidine ( AZA ) and
low‐dose cytarabine ( LD ‐ A ra‐ C ) in 65 palliative patients with acute myeloid leukemia ( …

Background Rituximab (R) in combination with DHAP is a widely accepted salvage regimen
for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). A common …

Dear Editor, Burkitt lymphoma (BL) is a highly aggressive non-hodgkin lymphoma (NHL)
representing about 1% of mature NHLs [1]. The German Multicenter Study Group for Adult ALL …

Monoclonal antibodies, such as PD-1 inhibitors, are increasingly used in various cancers.
Acute low back pain as infusion-related reaction (IRR) to monoclonal antibodies is poorly …

Objective Since medication errors can have severe consequences, the development of methods
to improve patient safety is becoming increasingly important. The aim of this evaluation …